Seattle-based biotech A-Alpha Bio moved out of the University of Washington’s Fluke Hall earlier this month and into just over 11,000 square feet of space in the Fourth & Blanchard building in Belltown. A-Alpha and its roughly 40-person team moved Dec. 10, and it now occupies about half of a floor in the 25-story office building. The biotech converted the space, as the building is not originally designed to accommodate lab work.
A-Alpha was founded in 2017 at UW’s Institute for Protein Design and the Center for Synthetic Biology. The company generates protein-interaction data. Younger said proteins function by sticking together, and understanding how proteins interact can lead to new treatments. Although the company’s internal work is focused on oncology, Younger said it does disease-based work through partnerships. A-Alpha in September 2021 raised a $20M Series A round led by Madrona Venture Group.